Clinical Trial Update: A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update for SHR-1918 in hypercholesterolemia patients not adequately controlled on statins plus PCSK9 inhibitors. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• PCSK9 inhibitors
• SHR-1918
• Statins

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Hypercholesterolemia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING